Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Alibaba Health Information Technology ( (HK:0241) ) has provided an announcement.
Alibaba Health Information Technology Limited has announced an updated list of its board of directors, effective December 15, 2025. The announcement outlines the roles and functions of each director, including the composition of the company’s board committees. This update is significant as it reflects the company’s strategic direction and governance structure, potentially impacting its operations and stakeholder relationships.
The most recent analyst rating on (HK:0241) stock is a Sell with a HK$4.60 price target. To see the full list of analyst forecasts on Alibaba Health Information Technology stock, see the HK:0241 Stock Forecast page.
More about Alibaba Health Information Technology
Alibaba Health Information Technology Limited operates in the health technology industry, focusing on providing digital health and wellness services. The company is known for leveraging technology to enhance healthcare delivery and accessibility.
YTD Price Performance: 60.54%
Average Trading Volume: 85,052,655
Technical Sentiment Signal: Hold
Current Market Cap: HK$86.18B
For an in-depth examination of 0241 stock, go to TipRanks’ Overview page.